Trial intelligence / Profile preview

Dasatinib treatment optimization in chronic myeloid leukemia (first-line and ≥ second-line)

2015-003502-16Phase 3Completed

Sponsor

Friedrich Schiller University Jena

Start

Jun 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1